Serum triglyceride, high-density lipoprotein cholesterol, apolipoprotein B, and coronary heart disease in a Chinese population undergoing coronary angiography

被引:17
|
作者
Ling, Yan [1 ]
Jiang, Jingling [1 ]
Wu, Bingjie [2 ]
Gao, Xin [1 ,3 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, 180 Fenglin Rd, Shanghai 200032, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Rheumatol, Shanghai, Peoples R China
[3] Fudan Univ, Inst Chron Metab Dis, Shanghai, Peoples R China
关键词
Triglyceride; Apolipoprotein B; High-density lipoprotein cholesterol; Coronary heart disease; Statin; LDL-CHOLESTEROL; METABOLIC SYNDROME; INSULIN-RESISTANCE; HDL CHOLESTEROL; RISK-FACTOR; ASSOCIATION; DISCORDANCE; DYSLIPIDEMIA; PARTICIPANTS; METAANALYSIS;
D O I
10.1016/j.jacl.2017.02.017
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Increased serum triglyceride and apolipoprotein B (apoB) levels and decreased high-density lipoprotein cholesterol (HDL-C) levels are risk factors for cardiovascular diseases. The major types of dyslipidemia in Chinese population are hypertriglyceridemia and low HDL-C. OBJECTIVE: This study aimed to evaluate the effect of HDL-C, triglyceride, and apoB levels on the risk of coronary heart disease (CHD) in a Chinese population undergoing coronary angiography. METHODS: This was a cross-sectional study. A total of 1941 consecutive patients who were referred to coronary angiography for the evaluation of suspected CHD were recruited. Lipid parameters were measured after an overnight fast. Patients were diagnosed with CHD and without CHD based on the findings of the coronary angiography. RESULTS: There were 1363 angiography confirmed CHD patients and 578 non-CHD patients. In nonstatin users, the major types of dyslipidemia were hypertriglyceridemia combined with low HDL-C, isolated low HDL-C, and isolated hypertriglyceridemia, accounting for 21.60%, 19.70%, and 14.99%, respectively. In statin users, a low to moderate-intensity statin was effective in lowering low-density lipoprotein cholesterol (LDL-C). The proportion of reaching an LDL-C goal <2.6 mmol/L and <1.8 mmol/L in statin users was 83.20% and 55.19%, respectively. In nonstatin users, the triglyceride and apoB levels were higher and the HDL-C levels were lower in CHD patients compared with non-CHD patients after the adjustment of age, sex, body mass index, diabetes, smoking, and alcohol drinking (P = .002,.007, and .005, respectively). After adjusting for age, sex, body mass index, diabetes, hypertension, smoking and alcohol drinking, the quartiles of triglyceride, HDL-C, and apoB were associated with CHD (P for trend = .001, .005, and.003, respectively). CONCLUSION: Serum triglyceride, HDL-C, and apoB levels were independently associated with CHD in a Chinese population undergoing coronary angiography with a relatively low level of LDL-C and a high prevalence of hypertriglyceridemia and low HDL-C. (C) 2017 National Lipid Association. All rights reserved.
引用
收藏
页码:646 / 656
页数:11
相关论文
共 50 条
  • [31] TRIGLYCERIDE, HIGH-DENSITY-LIPOPROTEIN, AND CORONARY HEART-DISEASE
    HALL, WH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (04): : 505 - 510
  • [32] High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography
    Alber, H. F.
    Wanitschek, M. M.
    de Waha, S.
    Ladurner, A.
    Suessenbacher, A.
    Doerler, J.
    Dichtl, W.
    Frick, M.
    Ulmer, H.
    Pachinger, O.
    Weidinger, F.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 (06) : 372 - 380
  • [33] Introduction to High-Density Lipoprotein, Dyslipidemia, and Coronary Heart Disease
    Schaefer, Ernst J.
    [J]. HIGH DENSITY LIPOPROTEINS, DYSLIPIDEMIA, AND CORONARY HEART DISEASE, 2010, : 1 - 14
  • [34] HIGH-DENSITY LIPOPROTEIN IN PREDICTION OF CORONARY HEART-DISEASE
    CRAIG, IH
    NEED, AG
    PAIN, RW
    PHILLIPS, PJ
    SOBECKI, S
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1980, 1 (08) : 393 - 393
  • [35] Novel insights on high-density lipoprotein in coronary heart disease
    Genest, J
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, : 17 - 22
  • [36] High-density lipoprotein particles, coronary heart disease, and niacin
    Asztalos, Bela F.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (05) : 405 - 410
  • [37] HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND RISK OF CORONARY HEART-DISEASE - FRAMINGHAM HEART STUDY EXPERIENCE
    CASTELLI, WP
    DAWBER, TR
    GORDON, T
    MCNAMARA, P
    KANNEL, WB
    [J]. JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, 1978, 55 (03) : A246 - A246
  • [38] SERUM TOCOPHEROL, CHOLESTEROL, AND TRIGLYCERIDE IN CORONARY HEART DISEASE
    NIKKILA, EA
    PELKONEN, R
    [J]. CIRCULATION, 1963, 27 (05) : 919 - &
  • [39] SERUM HIGH-DENSITY LIPOPROTEIN CHOLESTEROL CORRELATES WITH PRESENCE BUT NOT SEVERITY OF CORONARY-ARTERY-DISEASE
    SWANSON, JO
    PIERPONT, G
    ADICOFF, A
    [J]. AMERICAN JOURNAL OF MEDICINE, 1981, 71 (02): : 235 - 239
  • [40] High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality
    Silbernagel, Guenther
    Schoettker, Ben
    Appelbaum, Sebastian
    Scharnagl, Hubert
    Kleber, Marcus E.
    Grammer, Tanja B.
    Ritsch, Andreas
    Mons, Ute
    Holleczek, Bernd
    Goliasch, Georg
    Niessner, Alexander
    Boehm, Bernhard O.
    Schnabel, Renate B.
    Brenner, Hermann
    Blankenberg, Stefan
    Landmesser, Ulf
    Maerz, Winfried
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (46) : 3563 - 3571